by bgood | Oct 6, 2014 | code, hackathon, network, network of biothings, sulab
Can you code? Are you interested in the intersection of computer science and biology (bioinformatics) ? Do you want to meet interesting people? Are you excited about building new pieces of software that could change the face science and medicine? Do you want to win a...
by ginger | Oct 3, 2014 | mark2cure, sulab
Mark2Cure is a citizen science tool that empowers anyone who can read to make biomedical research literature more useful for researchers. Mark2Cure citizen scientists improve their ability to read and understand biomedical research abstracts while enabling researchers...
by ginger | Oct 2, 2014 | science, sulab, Thursday Science, wiki, work
For my dissertation research, I studied the mechanisms of viral persistence in the central nervous system using an in vitro model consisting of picornavirus infections of differentiated and undifferentiated murine neural progenitor and stem cells. To some of my...
by ginger | Sep 26, 2014 | BioThings, citizen science, crowdsourcing, mark2cure, sulab
We’ve posted a lot about the growing amount complex biomedical research and omics data that needs to be organized, integrated, and analyzed in order to be effectively applied. Similar issues apply to the growing volume of growing volume of biomedical research...
by ginger | Sep 19, 2014 | citizen science, crowdsourcing, mark2cure, sulab
In order to make the ever-growing body of biomedical research literature more useful for EVERYONE, the Su Lab at The Scripps Research Institute has been working on a citizen science-based approach to annotate biomedical research abstracts. The idea is that Mark2Cure...
by ginger | Sep 12, 2014 | citizen science, crowdsourcing, mark2cure, research, sulab
In case you missed why Open Access is awesome, the lack of open access is only one of many barriers that discourage the dissemination of scientific information to the public. Fortunately, more researchers are publishing in Open Access journals or with Open Access...
